Virios Therapeutics
R. Michael Gendreau has a vast experience in the medical field, serving as Chief Medical Officer in various companies including Virios Therapeutics, Intec Pharma Ltd., Cypress Bioscience, and MicroProbe. Currently, R. Michael is the President of Gendreau Consulting, LLC while also working as a Consulting Chief Medical Officer. Gendreau holds an M.D. from The Ohio State University College of Medicine and a BS in Chemistry from Ohio University.
This person is not in any offices
Virios Therapeutics
Virios Therapeutics is a clinical-stage biopharmaceutical company developing and commercializing innovative antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM).